Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aterian Inc (ATER) vs MakeMyTrip Ltd (MMYT) Price & Performance

Aterian IncTrade
MakeMyTrip LtdTrade

Price performance (Past 24H)

Key statistics

Aterian Inc vs MakeMyTrip Ltd — how do they compare? Aterian Inc trades at $1.25 (market cap $12.98M), while MakeMyTrip Ltd trades at $57.08 (market cap $5.29B). The key difference: MakeMyTrip Ltd is far larger — about 407.6× Aterian Inc's market cap, and Aterian Inc is trading nearer its 52-week high, MakeMyTrip Ltd nearer its low. Which is the better fit depends on your goals.

ATERMMYT
Market Cap
$12.98M$5.29B
Sector
Consumer CyclicalTechnology
52-Week High
$1.39$103.21
52-Week Low
$0.54$36.30
Enterprise Value
$13.56M$5.93B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aterian Inc

Aterian (ATER) trades at $1.19, up 3.48% with a bullish technical signal despite negative profitability. Recent earnings beats and a pending asset sale that could return $0.85-$1.14 per share provide near-term catalysts. However, the company shows declining revenue from $221M in 2022 to $69M in 2025, with negative net income margins and cash flow challenges.

The outlook hinges on shareholder approval of the brand portfolio sale, offering potential shareholder returns near current price levels. Investment opportunity exists in the asset sale catalyst, but risks include ongoing operational losses, declining revenue, and negative cash flow. Analyst sentiment is evenly split between Buy and Hold recommendations.

MakeMyTrip Ltd

MakeMyTrip (MMYT) trades at $57.08, down 2.63% today but maintains a bullish technical outlook with strong analyst support. The company demonstrates robust fundamentals with $978M revenue and $95M net income for 2025, though 2026 projections show margin compression. Recent earnings beats and a 73% gross margin highlight operational strength, while technical indicators show bullish moving averages despite recent price weakness.

The stock presents a compelling growth opportunity with strong analyst consensus (73% buy ratings) and consistent earnings outperformance. However, elevated P/E ratio (154.86) and projected margin pressure in 2026 warrant caution. Key risks include travel industry volatility and rising debt-to-asset ratio from 12% to 81% projected for 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aterian Inc

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Read more on ATER

About MakeMyTrip Ltd

MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.

Read more on MMYT